Corrections  by unknown
Corrections
In the article entitled, “Eaten Alive: Autophagy and Neu-
ronal Cell Death after Hypoxia-Ischemia” (Volume 172,
pages 284–287 of the February 2008 issue of The Amer-
ican Journal of Pathology), the sentence on page 285,
column 1, line 14 should have read, “. . . . 7 months of
life.”
In the article entitled, “A Critical Role for Rac1 in Tumor
Progression of Human Colorectal Adenocarcinoma Cells”
(Volume 172, pages 156–166), which appeared in the
January 2008 issue, Dr. Salvador A. Benitah was thanked
in the Acknowledgments when his contributions should
have been recognized as an author. The list of contrib-
uting authors should have been listed as follows: Carolina
Espina, Marı´a Virtudes Ce´spedes, Miguel Angel Garcı´a-
Cabezas, Marı´a Teresa Go´mez del Pulgar, Alicia Boluda,
Lourdes Garcı´a Oroz, Salvador A. Benitah, Paloma Ce-
jas, Manuel Nistal, Ramo´n Mangues, and Juan Carlos
Lacal. All authors have agreed to list Dr. Benitah as a full
author.
In the article entitled, “Genes Proximal and Distal to
MYCN Are Highly Expressed in Human Neuroblastoma
as Visualized by Comparative Expressed Sequence
Hybridization” (Volume 172, pages 203–214 of the Jan-
uary 2008 issue), the grant support information should
have included the following: “L.O. was supported by
GENAU-CHILD Projekt GZ200.136/1 - VI/1/2005 (to Re-
nate Panzer-Gru¨mayer).”
For the article entitled, “Polyunsaturated Fatty Acids In-
duce -Synuclein-Related Pathogenic Changes in Neuro-
nal Cells” (Volume 171, pages 2000–2011 of the December
2007 issue), the second author is incorrectly listed as Ev-
genia Yakonin in the print and online PDF versions of the
Table of Contents and the Index of Authors. The correct
listing of this author’s name is Evgenia Yakunin.
In the article entitled, “Islet -Cell-Specific T Cells
Can Use Different Homing Mechanisms to Infiltrate and
Destroy Pancreatic Islets” (Volume 170, pages 240–
250 of the January 2007 issue), the legend for Figure 5
contained errors. The corrected figure legend appears
below:
Figure 5. A: VCAM-1 blockade prevents islet destruction after effector T-
cell activation in PaLNs. RIP-mOVA mice were treated with function-
blocking anti-VCAM-1 (left) or anti-MAdCAM-1 (middle) or negative
controls after adoptive transfer of OT cells (see Materials and Methods).
Triangles represent blood glucose values (mmol/L) of individual mice at
10 days after transfer. Dashed line: cutoff value for hyperglycemia. Mean
insulitis scores  SEM (right) for pancreata from groups of mice that
remained normoglycemic at the end of the anti-VCAM-1 experiment (n 
5 per group). B: MAdCAM-1 (middle) but not VCAM-1 (left) blockade
diminishes islet destruction after effector T-cell activation in response to
oral antigen. RIP-OVAlo mice were treated with antibodies after adoptive
transfer of OT cells and administration of oral antigen (see Materials and
Methods). Mean insulitis scores  SEM (right) for pancreata from groups
of mice that remained normoglycemic at the end of the anti-MAdCAM-1
experiment (n  5 per group). C: Expression of the high-affinity
conformation of 1 integrin (activated 1) on OT-I cells after priming in
PaLN in response to islet-derived OVA compared with priming in
mesenteric (MLN) or peripheral lymph node (PLN) in response to oral or
subcutaneous OVA. Percentages indicate the proportion of cells in top left
quadrants (ie, cells divided 6 times and expressing activated 1).
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